Cleared Traditional

K200317 - Support Catheter

K200317 is an FDA 510(k) clearance for Support Catheter, manufactured by Qxmedical, LLC. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 97-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
97d
Days
Class 2
Risk

K200317 is an FDA 510(k) clearance for the Support Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Qxmedical, LLC (Saint Paul, US). The FDA issued a Cleared decision on May 14, 2020 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Qxmedical, LLC devices

FDA 510(k) Submission Details - K200317

510(k) Number K200317 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 2020
Decision Date May 14, 2020
Days to Decision 97 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d faster than avg
Panel avg: 125d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 780
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K200317.
Twin-Pass Dual Access Catheter
K193119 · Vascular Solutions, LLC · Jun 2020
Benchmark BMX96 Access System
K201271 · Penumbra, Inc. · Jun 2020
Agilis HisPro Steerable Catheter With Electrodes
K200721 · Abbott (St. Jude Medical) · Jun 2020
XO Cross Support Catheter
K193420 · Transit Scientific · May 2020
Q3 Distal Access Catheter, Q4 Distal Access Catheter, Q5 Distal Access Catheter, Q6Distal Access Catheter
K192558 · Mivi Neurovascular · Apr 2020
NovaCross CTO Microcatheter
K193322 · Nitiloop , Ltd. · Apr 2020